Updated 25 October 2026
Patient monitoring distributors in Bahrain: 10 independent, 11 licensed firms
The rest are manufacturers, their own import or sales entities or regulatory representatives. Every name is free to see, no sign-up.
This page covers patient monitor, neurology device and physiotherapy equipment distributors in Bahrain: the Index groups patient monitors, pulse oximetry, EEG and EMG, rehabilitation and wearable devices in one segment.
Listed
Independent distributors only. Patient monitoring specialists come first: the company name points to patient monitoring, or its registry records cover at most two segments. Broad-line distributors follow. Within each group, ranked by the lines each distributor carries for other manufacturers, then registrations held, then size.
- 176 lines52 registrationsSize score 74 of 100
- 251 lines2 registrationsSize score 41 of 100
- 341 lines1 registrationSize score 49 of 100
- 438 lines2 registrationsSize score 37 of 100
- 531 lines1 registrationSize score 46 of 100
- 626 lines11 registrationsSize score 50 of 100
- 712 lines2 registrationsSize score 36 of 100
- 89 lines28 registrationsSize score 55 of 100
- 92 lines2 registrationsSize score 29 of 100
- 101 line1 registrationSize score 30 of 100
Include manufacturers, their own sales entities and regulatory representatives (1)
Manufacturers, companies that are a manufacturer's own import or sales arm, and regulatory representatives (authorised representatives, sponsors or registration holders with no import or distribution role). They are registered here but are not independent distributors.
- 1Bahrain PharmacyManama12 lines33 registrationsSize score 66 of 100
Download the full list for Bahrain as CSV (38 establishments, all segments)
Is your company in this list? Claim it free. No one can pay to be listed or ranked.
Patient monitoring, neurology and physical medicine covers monitors, pulse oximetry, EEG and EMG, rehabilitation and wearable devices. Registries group a wide range of risk classes here, so the counts include both hospital capital equipment houses and consumer-grade device importers. Software and connectivity now feature in many registrations.
The Bastion Hale Distributor Index lists 11 establishments in Bahrain whose registry records include patient monitoring and neurology: 10 independent distributors (a channel role such as importer, distributor, wholesaler or authorised representative, and no manufacturing of their own), 0 manufacturers' own import or sales entities, 0 regulatory representatives, and 1 manufacturer or exporter, out of 38 medical device establishments in Bahrain overall. The records come from NHRA Bahrain, last seen on 23 October 2026.
Entry decision: patient monitoring and neurology in Bahrain
CE marked: go next, rank 40 of 124. FDA cleared: go next, rank 8 of 124. Show the full entry analysis
For a typical maker, from public data and the free Market Finder. Your own clearance, device class and current markets change the answer. The verdicts, best first: go now (route, channel and market size all work), go next (open, with one thing to solve first), build the case (two things to solve, or a full local registration in a large market), not now (blocked for this maker today).
CE marked, shipping from the EU
Go next the market is open, with one thing to solve first
Rank 40 of 124 markets for this maker.
Held back: a small market for this segment: health spending of USD 1.9bn (2023, World Bank).
Medium confidence: official registry in the Index without device categories, so the 10 confirmed in patient monitoring may understate the channel; registration route only partly confirmed in official sources.
FDA cleared, shipping from the US
Go next the market is open, with one thing to solve first
Rank 8 of 124 markets for this maker.
Held back: a small market for this segment: health spending of USD 1.9bn (2023, World Bank).
Medium confidence: official registry in the Index without device categories, so the 10 confirmed in patient monitoring may understate the channel; registration route only partly confirmed in official sources.
Registration route
With CE marking: CE opens a shorter reliance route. Medium confidence.
With FDA clearance: FDA opens a shorter reliance route. Medium confidence.
A local holder or authorised representative must hold or file the registration. Who holds the registration
Only an NHRA registered authorised representative may apply; registration relies on approval by a reference authority (FDA and EU national authorities among them).
Timeline and fees are not shown: no official source we cite gives them for this market yet. Confirm with a regulatory specialist before you plan a launch date. Sources: NHRA Bahrain, Medical Device Registration Guideline Ver 8.0.
Sales channel
Distributor-led: Foreign makers sell through distributors here. Only an authorised representative registered with NHRA can register a device; GCC agent practice.
US Commercial Service country guide, published .
Independent distributors in the Index: 10 for patient monitoring and neurology, 24 in Bahrain overall.
Makers registered here: 0 makers' own import or sales entities and 1 manufacturer.
Landed cost
Landed cost from the EU: about 5% collected at the border, about 5% real after credits (high confidence, from published tariff and tax rates). Duty about 5%, no import VAT or GST.
Landed cost from the US: no duty or import tax collected at the border (high confidence, from published tariff and tax rates).
Tariff basket: patient monitoring and neurology. Cash is collected at clearance. Real cost is what stays after a registered distributor recovers VAT and charges. Sources: Qatar Customs: GCC Integrated Customs Tariff 2026 schedule (PDF), NBR Imports and Exports VAT Guide v1.5 (updated 18 Jun 2026).
Market size
Health spending: USD 1.9bn in 2023, USD 1,176 per person (World Bank).
Whole market (TAM) for patient monitoring and neurology: about USD 3.2m to 13m a year (estimate, low confidence). TAM is all yearly spending on these devices in the market.
For one product line sold through distributors: SAM, the part of that spending distributors can reach, is about USD 250k to 1.5m a year. SOM, what a new maker with one good distributor could win a year after about three years, is about USD 3.8k to 37k (estimates). The free Market Finder sizes your own product range.
Broad scope, as in MedTech Europe figures: devices, diagnostics and consumables at manufacturer prices. Narrower published figures are lower.
How we estimate. At manufacturer prices.
Next step
The finder ranks every market for your own device, clearance and current markets. The CSV lists 38 establishments, the 24 independent distributors first. Company records only.
Neurology device distributors in Bahrain
EEG and EMG systems and other neurology devices are counted in this segment, next to patient monitors and pulse oximetry. Search the Index for neurology devices in Bahrain.
Physiotherapy equipment distributors in Bahrain
Rehabilitation and other physical medicine equipment is part of this segment as well. Registries group a wide range of risk classes here, so the list mixes hospital capital equipment houses and importers of consumer-grade devices. Search the Index for physiotherapy equipment in Bahrain.
All 10 independent patient monitoring distributors here name the manufacturers they represent, and their profiles list them.
By role
| Role | Establishments | Share | What it means |
|---|---|---|---|
| Distributor | 7 | 64% | Holds a distribution licence or is listed as distributor (Health Canada MDEL, SFDA, ANVISA, SAHPRA and other licence lists). |
| Authorised representative | 11 | 100% | Represents a foreign manufacturer towards the regulator: NHRA local agent. |
An establishment can hold several roles, so the shares add to more than 100%.
Who holds the registration in Bahrain
In the GCC a locally licensed importer or authorised representative must hold the device registration; a foreign manufacturer cannot hold it directly. If the distributor is also the registrant, it controls your market access. An independent local holder lets you appoint and replace distributors under it.
Who holds medical device registrations in Bahrain: the list
This is the general rule, not legal advice. The registration clause in the first distributor contract decides who controls the market later. The Next 10 Markets report covers who holds the registration in each of your ten markets.
Next steps
Questions about patient monitoring distributors in Bahrain
How many patient monitoring distributors are licensed in Bahrain?
The Index counts 11 establishments in Bahrain with patient monitoring and neurology in their registry record, of which 10 are independent distributors (a channel role and no manufacturing of their own). The number comes from NHRA Bahrain and was last refreshed on 25 October 2026.
Who distributes patient monitors in Bahrain?
The Index counts patient monitors with the other monitoring, neurology or physical medicine devices, so it does not list them separately. The highest ranked independent patient monitoring distributors in Bahrain on this page are Wael Pharmacy Co. W.L.L., Corporation for Technology W.L.L and Yousuf Mahmood Hussain Co W.L. L. Open a profile to see the makers each one represents.
Who can hold a patient monitoring and neurology device registration in Bahrain?
In the GCC a locally licensed importer or authorised representative must hold the device registration; a foreign manufacturer cannot hold it directly. If the distributor is also the registrant, it controls your market access. An independent local holder lets you appoint and replace distributors under it.
How do I find a patient monitoring distributor in Bahrain?
Open the top establishments on this page and check their roles, principals and registration counts. Then search the Index for your device and Bahrain to see the names, free, no sign-up. For a ranked shortlist for your device, see the Next 10 Markets report.
What does the Distributor Index count as a patient monitoring distributor in Bahrain?
A company that appears in a public regulatory registry with an address in Bahrain and whose linked device listings fall in the patient monitoring and neurology segment, in any of the roles importer, distributor, wholesaler, authorised representative, registration holder, manufacturer or exporter. Each company is counted once.
How are CE-marked and FDA-cleared patient monitoring and neurology devices registered in Bahrain?
With CE marking: CE opens a shorter reliance route. With FDA clearance: FDA opens a shorter reliance route. A local holder or authorised representative must hold or file the registration. Only an NHRA registered authorised representative may apply; registration relies on approval by a reference authority (FDA and EU national authorities among them). Confirm with a regulatory specialist before you plan a launch date.
How big is the patient monitoring and neurology market in Bahrain?
Health spending in Bahrain was USD 1.9bn in 2023 (World Bank). Bastion Hale estimates the patient monitoring and neurology market at about USD 3.2m to 13m a year at manufacturer prices. This is a model estimate with low confidence: health spending times the device share of health spending times the segment's share of world medical technology spending. The methodology page shows every input and source.
Other segments in Bahrain
Patient monitoring and neurology in other GCC markets
Sources
- Bahrain National Health Regulatory Authority medical device registration list: 11 establishments, last seen 23 October 2026. Public register.
- Company website (the establishment's own public site): 11 establishments, last seen 23 October 2026. Enrichment, not a registry: segments and principals read from the company's own website.
Index build 25 October 2026. Each establishment is counted once per country after resolving names across sources. Company records only, as the registries publish them.
Registry data. Bastion Hale does not vouch for any establishment.